-
Description
Fragmin 10000iu 1.00ml 10 (Dalteparin Sodium Injection)
Product Description:
Fragmin (Dalteparin Sodium Injection) is a low molecular weight heparin (LMWH) anticoagulant used for the prevention and treatment of thromboembolic disorders. It is formulated as a sterile, preservative-free solution for subcutaneous or intravenous administration. Each pre-filled syringe contains 10,000 international units (IU) of dalteparin sodium in a 1.00 ml solution, designed for precise dosing and ease of use.
Technical Specifications:
- Active Ingredient: Dalteparin sodium, 10,000 IU per 1.00 ml
- Administration: Subcutaneous or intravenous injection
- Packaging: Pre-filled syringe for single use
- Storage: Store at controlled room temperature; do not freeze
- Preservative-Free: Minimizes risk of allergic reactions
- Sterility: Ensures patient safety and product integrity
Common Applications:
- Prophylaxis of deep vein thrombosis (DVT) in surgical or bedridden patients
- Treatment of acute DVT with or without pulmonary embolism
- Prevention of ischemic complications in unstable angina and non-Q-wave myocardial infarction
- Extended treatment of symptomatic venous thromboembolism (VTE) in cancer patients
User Groups:
- Surgical patients at risk for thromboembolic events
- Patients with acute venous thromboembolism
- Individuals with unstable cardiovascular conditions
- Oncology patients requiring extended VTE treatment
Overview of Pfizer:
Pfizer is a global pharmaceutical leader with a long-standing reputation for developing innovative therapies. As the supplier of Fragmin, Pfizer leverages its extensive research and development capabilities to ensure the highest quality of anticoagulant products. With a commitment to patient safety and a robust portfolio of healthcare solutions, Pfizer stands as an authority in the anticoagulant space, providing trusted medications that meet stringent regulatory standards worldwide.
